Letter to the editor: Is NAFLD a bystander or contributor to coronary artery disease?

Affiliations

¹ Department of Liver Surgery, State Key Laboratory of Complex Severe and Rare Disease, Peking Union Medical College HospitalChinese Academy of Medical Sciences & Peking Union Medical CollegeBeijingChina.

Comment

Ziyu Xun et al. Hepatology. 2022 Dec.

. 2022 Dec;76(6):E127-E128.

doi: 10.1002/hep.32606. Epub 2022 Jul 21.

¹ Department of Liver Surgery, State Key Laboratory of Complex Severe and Rare Disease, Peking Union Medical College HospitalChinese Academy of Medical Sciences & Peking Union Medical CollegeBeijingChina.

No abstract available

Comment on

Relationship between NAFLD and coronary artery disease: A Mendelian randomization study.
Ren Z, Simons PIHG, Wesselius A, Stehouwer CDA, Brouwers MCGJ. Ren Z, et al. Hepatology. 2023 Jan 1;77(1):230-238. doi: 10.1002/hep.32534. Epub 2022 May 18. Hepatology. 2023. PMID: 35441719 Free PMC article.

1. Ren Z, Simons PIHG, Wesselius A, Stehouwer CDA, Brouwers MCGJ. Relationship between non‐alcoholic fatty liver disease and coronary artery disease: a Mendelian randomization study. Hepatology. 2022 Apr 20. https://doi.org/10.1002/hep.32534 [Epub ahead of print] - DOI
1. Lauridsen BK, Stender S, Kristensen TS, Kofoed KF, Køber L, Nordestgaard BG, et al. Liver fat content, non‐alcoholic fatty liver disease, and ischaemic heart disease: Mendelian randomization and meta‐analysis of 279 013 individuals. Eur Heart J. 2018;39(5):385–93.
1. Brouwers M, Simons N, Stehouwer CDA, Isaacs A. Non‐alcoholic fatty liver disease and cardiovascular disease: assessing the evidence for causality. Diabetologia. 2020;63:253–60.